You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Details for Patent: 11,433,083


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,433,083 protect, and when does it expire?

Patent 11,433,083 protects TLANDO and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 11,433,083
Title:High-strength testosterone undecanoate compositions
Abstract:The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. The capsule fill can include a solubilizer and about 14 wt % to about 35 wt % testosterone undecanoate based on the total capsule fill. The oral dosage capsule is such that when a single oral administration to a male subject of one or more capsules with a total testosterone undecanoate daily dose of about 350 mg to about 650 mg it provides a ratio of serum testosterone Cmax to serum testosterone Cave of about 2.7 or less. In yet another embodiment, a method for providing a serum concentration of testosterone within a target serum testosterone concentration Cave range for a male subject is provided.
Inventor(s):Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Assignee:Lipocine Inc
Application Number:US16/412,360
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a Patent: A Detailed Analysis of United States Patent 11,433,083

Introduction to Patents and Patent Scope

Patents are intellectual property rights granted to inventors for their innovative creations, providing exclusive rights to make, use, and sell the invention for a specified period. The scope and claims of a patent are crucial as they define the boundaries of the invention and determine what is protected.

The Importance of Patent Scope

Patent scope is a critical aspect of patent quality and is often debated in the context of patent breadth, clarity, and validity. A narrower patent scope can lead to a higher probability of grant and a shorter examination process, while broader claims may face more scrutiny and potential litigation[3].

Tools for Analyzing Patents

To analyze the scope and claims of a patent, several tools and resources are available:

Global Dossier

The Global Dossier service provided by the USPTO allows users to access file histories of related applications from participating IP Offices. This includes viewing the patent family, dossier, classification, and citation data, as well as identifying office actions and saving documents for later review[1].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers access to patent and trademark information in various formats. Trained staff are available to assist users, and additional resources include local Patent and Trademark Resource Centers and the USPTO Main STIC Library[1].

Search Published Sequences

For patents involving sequences, the Publication Site for Issued and Published Sequences (PSIPS) provides access to sequence listings and tables for granted US patents or published US patent applications[1].

Analyzing Patent Claims

Metrics for Measuring Patent Scope

Two simple metrics for measuring patent scope are independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, the breadth of patent classes, and novelty[3].

Claim Language

The language used in patent claims is vital. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process often narrows the scope of patent claims in terms of both claim length and claim count[3].

Case Study: United States Patent 11,433,083

To illustrate the analysis of patent scope and claims, let's consider United States Patent 11,433,083.

Patent Details

  • Patent Title: The title of the patent provides a brief description of the invention.
  • Abstract: The abstract gives a concise summary of the invention.
  • Claims: The claims section is where the inventor defines what is protected by the patent. This includes independent and dependent claims.
  • Description: The detailed description of the invention explains how it works and its various embodiments.

Claim Analysis

  • Independent Claims: These are the broadest claims that define the invention. Analyzing the length and count of independent claims can provide insights into the patent's scope.
  • Dependent Claims: These claims are narrower and depend on the independent claims. They further define specific aspects of the invention.

Scope Determination

Using tools like the Global Dossier, you can see the patent family and related applications to understand the broader context of the invention. This helps in determining the scope by identifying similar inventions and how they are differentiated.

Office Actions and Examination Process

Office Action Indicators in the Global Dossier can help identify any office actions taken during the examination process. This can provide insights into how the patent scope was narrowed or broadened during the examination.

Valuation of Patents

Understanding the scope and claims of a patent is also crucial for its valuation. Here are three common valuation methods:

Cost Approach

This method considers the cost of developing the patent, which includes research, development, and legal fees[4].

Income Approach

This method looks at the future benefits provided by the patent, such as income or savings, and calculates the present value of these benefits over the patent's lifetime[4].

Market Approach

This method determines the market value by looking at what a willing buyer would pay for a similar patent. It involves analyzing sales and asking price data for comparable patents[4].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, which could impact the valuation and enforcement of patents[5].

Key Takeaways

  • Patent Scope: Narrower claims are generally associated with a higher probability of grant and a shorter examination process.
  • Claim Analysis: Independent claim length and count are useful metrics for measuring patent scope.
  • Valuation: The cost, income, and market approaches are used to value patents, with each method considering different aspects of the patent's value.
  • Legal Considerations: The potential establishment of a small claims patent court could impact patent litigation and enforcement.

FAQs

What is the importance of patent scope in the patent examination process?

Patent scope is crucial as it determines the boundaries of the invention. Narrower claims are associated with a higher probability of grant and a shorter examination process.

How can I analyze the claims of a patent like United States Patent 11,433,083?

You can use tools like the Global Dossier to view the patent family and related applications. Analyze the independent and dependent claims to understand the scope of the invention.

What are the common methods for valuing a patent?

The common methods include the cost approach, income approach, and market approach. Each method considers different aspects of the patent's value.

What is the Global Dossier service provided by the USPTO?

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, including viewing the patent family, dossier, classification, and citation data.

Why is there a discussion about a small claims patent court?

The discussion is aimed at addressing the high costs and complexity of patent litigation. A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Perpetual Motion Patents - The value of a patent: https://perpetualmotionpatents.com/the-value-of-a-patent/
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,433,083

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Verity TLANDO testosterone undecanoate CAPSULE;ORAL 208088-001 Mar 28, 2022 RX Yes Yes 11,433,083 ⤷  Try for Free TESTOSTERONE REPLACEMENT THERAPY IN ADULT MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE; PRIMARY HYPOGONADISM (CONGENITAL OR ACQUIRED); HYPOGONADOTROPIC HYPOGONADISM (CONGENITAL OR ACQUIRED). ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,433,083

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2012075081 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.